These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8804040)

  • 1. The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific.
    Lovestone S; Anderton BH; Hartley C; Jensen TG; Jorgensen AL
    Neuroreport; 1996 Apr; 7(5):1005-8. PubMed ID: 8804040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism.
    Roses AD; Einstein G; Gilbert J; Goedert M; Han SH; Huang D; Hulette C; Masliah E; Pericak-Vance MA; Saunders AM; Schmechel DE; Strittmatter WJ; Weisgraber KH; Xi PT
    Ann N Y Acad Sci; 1996 Jan; 777():146-57. PubMed ID: 8624078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E gene and Alzheimer's disease: is tau the link?
    Lovestone S; Anderton B; Betts J; Dayanandan R; Gibb G; Ljungberg C; Pearce J
    Biochem Soc Symp; 2001; (67):111-20. PubMed ID: 11447827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.
    Golombowski S; Müller-Spahn F; Romig H; Mendla K; Hock C
    Neurosci Lett; 1997 Apr; 225(3):213-5. PubMed ID: 9147408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation.
    Huang DY; Weisgraber KH; Goedert M; Saunders AM; Roses AD; Strittmatter WJ
    Neurosci Lett; 1995 Jun; 192(3):209-12. PubMed ID: 7566652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.
    Montine KS; Bassett CN; Ou JJ; Markesbery WR; Swift LL; Montine TJ
    J Lipid Res; 1998 Dec; 39(12):2443-51. PubMed ID: 9831633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease.
    Huang DY; Goedert M; Jakes R; Weisgraber KH; Garner CC; Saunders AM; Pericak-Vance MA; Schmechel DE; Roses AD; Strittmatter WJ
    Neurosci Lett; 1994 Nov; 182(1):55-8. PubMed ID: 7891887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE is a major susceptibility gene for Alzheimer's disease.
    Roses AD; Saunders AM
    Curr Opin Biotechnol; 1994 Dec; 5(6):663-7. PubMed ID: 7765750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E in Alzheimer's disease: an update.
    Yu JT; Tan L; Hardy J
    Annu Rev Neurosci; 2014; 37():79-100. PubMed ID: 24821312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and Alzheimer disease.
    Strittmatter WJ; Roses AD
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4725-7. PubMed ID: 7761390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
    Leoni V
    Clin Chem Lab Med; 2011 Mar; 49(3):375-83. PubMed ID: 21388338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apolipoprotein E: the Alzheimer's disease connection.
    Weisgraber KH; Mahley RW
    FASEB J; 1996 Nov; 10(13):1485-94. PubMed ID: 8940294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.
    Blomberg M; Jensen M; Basun H; Lannfelt L; Wahlund LO
    Neurosci Lett; 1996 Aug; 214(2-3):163-6. PubMed ID: 8878109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
    Rao S; Ghani M; Guo Z; Deming Y; Wang K; Sims R; Mao C; Yao Y; Cruchaga C; Stephan DA; Rogaeva E
    Neurobiol Aging; 2018 Jun; 66():178.e1-178.e8. PubMed ID: 29395286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.